KINIKSA PHARMACEUTICALS (UK), LTD.

Company number 11716038 ·

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Shareholders' funds

£65,807

Balance sheet as at 2020-12-31

View full accounts →

Overview

Company type
Private Limited Company
Incorporated
2018-12-06
Employees
2 (2020 accounts)
Registered office
105 Piccadilly, Second Floor, London, England, W1J 7NJ
Postcode
W1J 7NJ
Capital
4 GBP
Accounts category
Audit Exemption Subsidiary

Accounts

Last made up to
2024-12-31
Next due by
2026-09-30
Financial year end
31 December

Confirmation statement

Last statement dated
2025-11-14
Next due by
2026-11-28
View filing history →

Nature of business (SIC)

  • 21100 Manufacture of basic pharmaceutical products

Officers 6 current · 7 resigned

Douglas BARRY Secretary
Appointed 2025-09-17
Appointed 2021-06-11
Appointed 2021-03-08
DIRECTOR Appointed 2020-03-20
MR THOMAS BEETHAM Secretary
Appointed 2018-12-06

View all officers and resignations →

Group structure

Controlled by PUNCH TAVERNS (PR) LIMITED — since 2018-12-06

From persons-with-significant-control filings on the public register.

Contact details

Website
kiniksa.org
Phone
034282443, 034285151, 0629311997

Kiniksa Pharmaceuticals is a biopharmaceutical company that believes every second makes a difference for patients living with debilitating diseases.

Among its peers

Top 25%

by shareholders' funds, of 31 similar companies in W

Trading since 2018.

No.7 of the largest manufacture of basic pharmaceutical products companies in London →

140 companies are registered at this postcode →

Competitors London

This company ranks 7 among manufacture of basic pharmaceutical products in London.

Full league table →

The class of 2018

30%

of the 669,398 companies incorporated in 2018 are still active today; 63% have since been dissolved.

A fact about the year, not a forecast for this company.

Survival rates for every incorporation year →